Nobuyoshi Hiraoka

31PUBLICATIONS
124CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedCancer diagnosisPredictive and prognostic markersHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 05, 2026
PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

|Aug 14, 2026
Novel insights into immunohistochemical analysis of intrahepatic cholangiocarcinoma: ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GalNAc1) as a new marker for large duct type.

|Jun 12, 2026
Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors.

|Mar 02, 2026
Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass-Forming Intrahepatic Cholangiocarcinoma.

Naoto Kubota, Ken Yamazaki, Yasuhito Arai

|Jan 31, 2026
Bile duct tumor thrombus (intraductal polypoid growth)-positive intrahepatic cholangiocarcinoma: clinicopathologic and genomic analysis.

Ayaka Mitsui, Minoru Esaki, Satoshi Nara

|Sep 02, 2025
Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity.

Junko Sawada, Yasuhiro Kikuchi, Maxwell Duah

Pageof 6

Frequent Collaborators

4 joint publications

Shigehisa Kitano

4 joint publications

Kazunori Aoki

4 joint publications

Noriko Motoi

4 joint publications

Tatsuhiro Shibata